Examples of 'tissue plasminogen' in a sentence
Meaning of "tissue plasminogen"
tissue plasminogen: This phrase refers to a protein involved in the breakdown of blood clots, specifically in the medical field when discussing coagulation processes, thrombosis, or fibrinolysis
How to use "tissue plasminogen" in a sentence
Basic
Advanced
tissue plasminogen
Tissue plasminogen activators are found in many tissues.
Recombinant tissue plasminogen activator.
Tissue plasminogen activator human.
This medication is called tissue plasminogen activator or tPA treatment.
Tissue plasminogen activator is released by endothelial cells and activated platelets.
Fibrin is a cofactor for plasminogen activation by tissue plasminogen activator.
Stabilized human tissue plasminogen activator compositions.
This drug blocks the production of plasminogen and tissue plasminogen activator.
Take a tissue plasminogen activator to dissolve the clot.
The commercial production of recombinant human tissue plasminogen activator is an example.
It is a tissue plasminogen activator.
Physical exercise enhances endogenous fibrinolytic activity manifested as a reduction in tissue plasminogen activator.
It also inhibits tissue plasminogen activator and urokinase.
The signal sequence was a modified prepro sequence from human tissue plasminogen activator.
Production of tissue plasminogen activators from animal cells.
See also
The active enzyme also appears to increase fibrinolysis by activating tissue plasminogen activator inhibitor.
Recombinant tissue plasminogen activators.
A process according to any of the preceding claims wherein said protein is a tissue plasminogen activator.
Tissue plasminogen activator glycosylation variants with improved therapeutic properties.
Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.
Tissue plasminogen activator analogs having modified growth factor domains.
Milk from the transgenic dairy goat contained the modified tissue plasminogen activator.
Tissue plasminogen activators are produced in human blood but only in extremely small amounts.
This part of the present polypeptide is derived from a native tissue plasminogen activator polypeptide.
Intravenous thrombolysis with tissue plasminogen activator is the only treatment for stroke with proved benefit.
The thrombolytic agent used in the present invention is preferably tissue plasminogen activator or urokinase.
Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
Further thrombotic events could be treated with Tissue plasminogen activator tPA.
In addition, tissue plasminogen activator is now being developed.
Preferably, the thrombolytic agent is a human tissue plasminogen activator.
Further, the recombinant tissue plasminogen activator can be alteplase, reteplase or tenecteplase.
Eton et al . implanted myointimal cells transduced with tissue plasminogen activator genes.
Tissue plasminogen activator binds to plasminogen within the clot, converting it into plasmin.
The authors employed a purification scheme that affords tissue plasminogen activator at relatively high purity levels.
Tissue plasminogen activator ( tPA ) is a serine protease induces opening of the blood brain barrier.
Annexin II organizes the assembly of tissue plasminogen activator and plasminogen on its surface.
Particularly preferred thrombolytics are urokinase, streptokinase, and the tissue plasminogen activators.
However, typical thrombolysis with tissue plasminogen activator, urokinase or streptokinase is problematic.
The method of claim 4, wherein the thrombolytic agent is a tissue plasminogen activator.
He was given a drug known as tissue plasminogen activator, or tPA, which dissolves blood clots.
In a more preferred embodiment the antithrombotic is recombinant tissue plasminogen activator ( tPA ).
Exemplary clot dissolving agents are tissue plasminogen activator, streptokinase, urokinase and heparin.
More preferably, the thrombolytic agent is recombinant human tissue plasminogen activator.
More specifically, it relates to tissue plasminogen activator analogs having a modified kringle domain.
The term " fibrinolytic agent " shall include streptokinase and tissue plasminogen activator.
Preferred clot dissolving agents are tissue plasminogen activator, streptokinase, urokinase and heparin.
The term " thrombolytic agent " shall include streptokinase and tissue plasminogen activator.
Surgical trauma releases the tissue plasminogen activator t-PA and the fibrinolytic system is activated.
Suitable antithrombogenic agents are prostaglandins, urokinase, streptokinase, tissue plasminogen activator and heparinoids.
More specifically, it relates to tissue plasminogen activator analogs having a modified growth factor domain.
You'll also be interested in:
Examples of using Plasminogen
Show more
So to replace the plasminogen in the first place
Plasmin is a serine protease derived from plasminogen
Tissue plasminogen activators are found in many tissues
Examples of using Tissue
Show more
New tissue paper with ftoral fragrance
Clonal selection versus tissue culture production
Tissue death due to clots in the bloodstream
